August 9, 2019
Athena Countouriotis is the CEO of Turning Point Therapeutics, among the San Diego biotechs that added space in the second quarter. Photo courtesy of Turning Point Therapeutics.
Stories this photo appears in:
Expansions By Some Of the Bigger Players Are Expected in Q3
The leasing footprint of San Diego life sciences companies grew by 263,399 square feet in the second quarter, according to report from the brokerage firm JLL.